过敏性鼻炎患者免疫治疗前后鼻部细菌微生物组比较
本研究为横断面比较,采集未接受免疫治疗的过敏性鼻炎患者、接受免疫治疗超过12个月的过敏性鼻炎患者及无鼻窦炎性疾病的对照组鼻拭子进行微生物组分析。结果显示三组间β多样性显著不同,但两个过敏性鼻炎组彼此更相似,免疫治疗虽改善症状,微生物组并未转变为健康组成。
要点
- 三组间鼻部微生物β多样性显著不同,但两个过敏性鼻炎组间更相似。
- 免疫治疗超过12个月的过敏性鼻炎患者症状改善,但微生物组未转为健康组成。
- 棒状杆菌属和葡萄球菌属在所有组中均为最优势菌属。
核心结论
- 三组间β多样性显著不同,但两个过敏性鼻炎组彼此更相似而非与对照组相似。
- 免疫治疗虽改善过敏性鼻炎症状,但鼻部微生物组并未转变为健康微生物组成。
研究设计与样本
- 横断面比较研究,采集三组患者鼻拭子进行微生物组分析。
- 三组分别为未接受免疫治疗的过敏性鼻炎患者14例、接受免疫治疗超过12个月的过敏性鼻炎患者20例、无鼻窦炎性疾病的对照组17例。
主要发现
- α多样性显示均匀度有统计学差异,但丰富度无统计学差异。
- β多样性在组间显著不同。
- 棒状杆菌属和葡萄球菌属在所有组中均为最常检出的细菌。
- 两个过敏性鼻炎组之间的微生物组相似性高于与对照组之间的相似性。
临床怎么用
- 免疫治疗期间过敏性鼻炎症状改善不一定伴随鼻部微生物组向健康组成转变。
- 评估免疫治疗疗效时,鼻部微生物组组成变化可能不是必要的监测指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Recent research has examined the nasal microbiome in rhinosinusitis and nondiseased states. Given immunologic alterations in allergic rhinitis (AR) and after allergen immunotherapy (IT), we evaluated the nasal microbiome in these conditions. STUDY DESIGN: Cross-sectional comparison. METHODS: In this cross-sectional study, nasal swabs for microbiome analysis were collected from three patient groups: IT-naïve AR patients, AR patients undergoing IT for greater than 12 months, and a control group without sinonasal inflammatory disease. RESULTS: Nasal swabs were successfully collected for 14 IT-naïve AR patients, 20 post-IT patients, and 17 controls. The α diversity showed a statistical difference in evenness but not in richness amongst samples, whereas the β-diversity was significantly different between groups. Corynebacterium and Staphylococcus were the most prevalent bacteria across all groups. CONCLUSIONS: β-diversity was found to be significantly different across the three groups, but the AR groups were found to be more similar to each other than to the controls. Although there is symptomatic improvement in the AR group undergoing IT, the microbiome does not appear to transition to a healthy microbiome composition. LEVEL OF EVIDENCE: 4 Laryngoscope, 2020.
引用
- Bender ME, Read TD, Edwards TS, et al. A Comparison of the Bacterial Nasal Microbiome in Allergic Rhinitis Patients Before and After Immunotherapy. Laryngoscope. 2020. PMID: 32181890. doi:10.1002/lary.28599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。